Table of Contents:
  • 880-01 Prognostic and therapeutic targets in the Ewing's family of tumors (PROTHETS) / P. Picci [and others]
  • Targeted therapies in Ewing's sarcoma / K. Scotlandi
  • The CCN3 protein and cancer / B. Perbal
  • EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage / J. Ban [and others]
  • Molecular karyotyping in sarcoma diagnostics and research / H. Vauhkonen [and others]
  • TuBaFrost: European virtual tumor tissue banking / P.H.J. Riegman [and others]
  • Virtual microscopy in virtual tumor banking / M. Isabelle [and others]
  • Harmonizing cancer control in Europe / U. Ringborg
  • The diagnosis of cancer: from H & E to molecular diagnosis and back / J. Costa
  • From morphological to molecular diagnosis of soft tissue tumors / M. Miettinen
  • Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract / H. Höfler [and others]
  • Integrating the diagnosis of childhood malignancies / D. López-Terrada
  • Preclinical models for cell cycle-targeted therapies / M. Malumbres
  • WWOX, a chromosomal fragile site gene and its role in cancer / D. Ramos and C.M. Aldaz
  • From genome to proteome in tumor profiling: molecular events in colorectal cancer genesis / J.K. Habermann [and others]
  • Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models / L. Holmquist, T. Löfstedt, and S. Påhlman
  • Methylation patterns and chemosensitivity in NSCLC / J.L. Ramírez [and others]
  • Pharmacogenomics and colorectal cancer / H.J. Lenz
  • Development of pharmacogenomic predictors for preoperative chemotherapy of breast cancer / L. Pusztai
  • Vascular endothelial growth factor inhibitors in colon cancer / E. Díaz-Rubio
  • Molecular imaging of cancer using PET and SPECT / A. Kjær
  • MRS as endogenous molecular imaging for brain and prostate tumors: FP6 project "eTUMOR" / B. Celda [and others]
  • From Linac to tomotherapy: new possibilities for cure? / G. Storme [and others]
  • Targeting mTOR for cancer treatment / B. Rubio-Viqueira and M. Hidalgo
  • Dual/pan-her tyrosine kinase inhibitors: focus in breast cancer / J. Albanell
  • Antitumor-associated antigens IGGS: dual positive and negative potential effects for cancer therapy / E. Barberá Guillem and J.W. Sampsel
  • Synergistic molecular mechanisms in hormone-sensitive breast cancer / A. Llombart Cussac.